The initial daclatasvir NDA submitted by the company to the FDA focused on the drug’s use in combination with asunaprevir, an NS3/4A protease inhibitor. Given the withdrawal of
FTC has also approved creation of a consumer healthcare joint venture (JV) by combining GSK’s Consumer Healthcare business and Novartis’ over-the-counter (OTC) Consumer Healthcare business. Novartis has agreed
The new vaccine candidate was co-developed by the National Institutes of Health’ (NIH) National Institute of Allergy and Infectious Diseases (NIAID) and Okairos, a biotechnology firm acquired by
Also known as Selincro, nalmefene is designed to be prescribed as a once-daily tablet to people who drink alcohol regularly. The drug helps those people who want to
The Hatfield production plant is operated by the company’s UK manufacturing subsidiary, Eisai Manufacturing. UK Minister for Life Sciences George Freeman said: "Pharmaceuticals manufacturing is important to our
Trulicity, a GLP-1 receptor agonist, is a once-weekly, injectable solution and it comes in a ready-to-use pen with a pre-attached, hidden needle. In September, Trulicity received a positive
Patient enrollment in the trial is being carried out at European oncology centers such as Radboud University Medical Center in the Netherlands), the Jules Bordet Institute in Belgium
OBT357 is a defucosylated, recombinant, humanized antibody targeting an undisclosed antigen expressed on AML blasts and the AML stem cell compartment. The trial is the first of five
In NMO patients, chronic, uncontrolled complement activation results in severe damage to the central nervous system (CNS), mainly impacting the optic nerve and spinal cord. This disease is
Haemophilia A is a rare chronic bleeding disorder that leads to inadequate clotting of the blood in response to any type of injury or surgery. Patients with haemophilia
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.